Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy

被引:4
|
作者
Zhang, Hao [1 ]
Huo, Junyu [1 ]
Jiang, Wanying [1 ]
Shan, Qijun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
关键词
dilated cardiomyopathy; hub gene; gene expression omnibus; bioinformatics; ACUTE KIDNEY INJURY; HEART-FAILURE; INTERNATIONAL-SOCIETY; TASK-FORCE; PROENKEPHALIN; DYSFUNCTION; DOXORUBICIN; EXPRESSION; IDENTIFICATION; MANAGEMENT;
D O I
10.3892/mmr.2020.11145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dilated cardiomyopathy (DCM) is a primary cardiomyopathy with high mortality. The aim of the present study was to identify the related genes in DCM. The four expression profiles (GSE17800, GSE21610, GSE42955 and GSE79962) downloaded from the Gene Expression Omnibus (GEO) database were analyzed using RankProd and metaMA R packages to identify differentially expressed genes (DEGs). DEGs were uploaded to the Database for Annotation, Visualization and Integrated Discovery (DAVID), for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. A protein-protein interaction (PPI) network of the DEGs was constructed using the STRING database. In addition, hub genes were identified using the Cytoscape plugin cytoHubba. A mouse DCM model, which established via intraperitoneal injection with doxorubicin (DOX), was used to validate the hub genes. A total of 898 DEGs were identified across the four microarrays. Furthermore, GO analysis demonstrated that these DEGs were mainly enriched in cell adhesion, negative regulation of cell proliferation, negative regulation of apoptotic process and potassium ion transport. In addition, KEGG analysis revealed that DEGs were mainly enriched in the ECM-receptor interaction, the p53 signaling pathway, cardiac muscle contraction and the hypoxia-inducible factor signaling pathway. Proenkephalin (PENK), chordin like 1 (CHRDL1), calumenin (CALU), apolipoprotein L1, insulin-like growth factor binding protein 3 (IGFBP3) and ceruloplasmin (CP) were identified as hub genes in the PPI network. Furthermore, the expression levels of PENK, CHRDL1, IGFBP3, CP and CALU in hearts with DCM were validated using a mouse model. In conclusion, the present study identified six hub genes related to DCM. Therefore, the present results may provide a potential mechanism for DCM involving these hub genes, which may serve as biomarkers for screening and diagnosis in the clinic.
引用
收藏
页码:915 / 925
页数:11
相关论文
共 50 条
  • [1] Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
    Wang, Zuoxiang
    Xia, Qingyue
    Su, Wenxing
    Cao, Mingqiang
    Sun, Yunjuan
    Zhang, Mingyang
    Chen, Weixiang
    Jiang, Tingbo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [2] Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy
    Yang, Yujiao
    Liu, Ping
    Teng, Ruoling
    Liu, Fenfen
    Zhang, Cuiping
    Lu, Xiang
    Ding, Yi
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (06)
  • [3] Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction
    Yvan Devaux
    Francisco Azuaje
    Mélanie Vausort
    Céline Yvorra
    Daniel R. Wagner
    Functional & Integrative Genomics, 2010, 10 : 329 - 337
  • [4] Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction
    Devaux, Yvan
    Azuaje, Francisco
    Vausort, Melanie
    Yvorra, Celine
    Wagner, Daniel R.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2010, 10 (03) : 329 - 337
  • [5] Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis
    Shi, Kaijia
    Chen, Xu
    Zhao, Yangyang
    Li, Peihu
    Chai, Jinxuan
    Qiu, Jianmin
    Shen, Zhihua
    Guo, Junli
    Jie, Wei
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [6] Proteomic Analysis of Gallbladder Cancer to Identify Biomarkers and Therapeutic Targets
    Barbhuiya, Mustafa A.
    Subbannayya, Tejaswini
    Leal-Rojas, Pamela A.
    Shahasrabudhe, Nandini
    Renuse, Santosh
    Patil, Arun H.
    Garcia, Patricia
    Navani, Sanjay
    Tiwari, Pramod K.
    Santosh, Vani
    Prasad, T. S. Keshava
    Gowda, Harsha
    Yadav, Thakur D.
    Roa, Juan C.
    Chatterjee, Aditi
    Pandey, Akhilesh
    GASTROENTEROLOGY, 2015, 148 (04) : S571 - S571
  • [7] Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma
    Zhou, Xuezhi
    Rong, Rong
    Xiong, Siqi
    Song, Weitao
    Ji, Dan
    Xia, Xiaobo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] THE INTEGRATED USE OF HUMAN MODELS OF LEUKEMIA TO IDENTIFY POTENTIAL THERAPEUTIC TARGETS
    Wilhelm, Brian
    Milan, Thomas
    Celton, Magalie
    Lagace, Karine
    Roques, Elodie
    Bresson, Eva
    Bergeron, Anne
    Hebert, Josee
    Lamontagne, Vikie
    Cellot, Sonia
    Barabe, Frederic
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S92 - S93
  • [9] Integrative -Omics Identify Potential Biomarkers and Therapeutic Targets for Idiopathic Pulmonary Fibrosis
    Yang, C.
    Milne, S.
    Allen, R.
    Cordero, A. I. Hernandez
    Li, X.
    Ayoub, A.
    Ask, K.
    Hirota, J. A.
    Bosse, Y.
    Timens, W.
    Hao, K.
    Sin, D. D.
    Jenkins, G.
    Wain, L. V.
    Obeidat, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis
    Gatasheh, Mansour K.
    Natarajan, Sathan Raj
    Krishnamoorthy, Rajapandiyan
    Alsulami, Tawfiq S.
    Rajagopal, Ponnulakshmi
    Palanisamy, Chella Perumal
    Veeraraghavan, Vishnu Priya
    Jayaraman, Selvaraj
    MOLECULAR & CELLULAR ONCOLOGY, 2024, 11 (01)